0% found this document useful (0 votes)
3 views23 pages

Preformulation Studies

The document discusses preformulation studies focusing on the physicochemical characterization of new drug molecules, emphasizing solubilization, stability analysis, and drug-excipient compatibility. It details methods for increasing solubility, measuring partition coefficients, and evaluating stability under various conditions. Additionally, it outlines the importance of understanding drug stability mechanisms and the Biopharmaceutical Classification System (BCS) for drug development.

Uploaded by

Sameer Budhiraja
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
3 views23 pages

Preformulation Studies

The document discusses preformulation studies focusing on the physicochemical characterization of new drug molecules, emphasizing solubilization, stability analysis, and drug-excipient compatibility. It details methods for increasing solubility, measuring partition coefficients, and evaluating stability under various conditions. Additionally, it outlines the importance of understanding drug stability mechanisms and the Biopharmaceutical Classification System (BCS) for drug development.

Uploaded by

Sameer Budhiraja
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 23

PREFORMULATION

STUDIES:
PHYSICOCHEMICAL
CHARACTERIZATION OF
NEW DRUG MOLECULES

1
SOLUBILIZATION

Solubilization is defined as the spontaneous


passage of poorly water soluble solute
molecules into an aqueous solution of a soap
or detergent in which a thermodynamically
stable solution in formed

2
It is the process by which apparent solubility of an otherwise
sparingly soluble substance is increased by the presence of surfactant
micelles .

 MICELLES: -

 The mechanism involves the property of surface active agents


to form colloidal aggregates known as micelles .

3
 When surfactants are added to the liquid at low concentration they
tend to orient at the air-liquid interface .

 On further addition of surfactant the interface becomes completely


occupied and excess molecules are forced into the bulk of liquid.

At very high concentration surfactant molecules in the bulk of liquid


begin to form micelles and this concentration is know as CRITICAL
MICELLE CONCENTRATION (CMC)

4
General Method of Increasing
the Solubility
 Addition of co-solvent
 pH change method
 Reduction of particle size
 Temperature change method
 Addition of Surfactant
 Dielectrical Constant
 Complexation

5
Partition Coefficient
 A measurement of drug lipophilicity i,e the ability to cross the cell
membrane p 
o/a
c o rg a n ic
c aque ous
Distribution coefficient ( pH  pKa )
log D  log P  log (1 10 )
 For acids: 10 10
10

pKa  pH

 For bases : log 10


D  log P  l o g (1  1 0
10
)
10

 The octanol-water system is widely accepted to explain these phenomenon.


 Buccal membrane : butanol-pentanol system
 Blood-Brain barrier: chloroform-cyclohexane
 Determined by SHAKE FLASK METHOD

6
SHAKE FLASK METHOD

 Drug is shaken between octanol and water.


 Aliquot is taken and analyzed for drug content

RULE OF FIVE : for drug permeates through passive diffusion

1. Log P not greater than 5

2. Molecular weight >500

3. There are more than 5 hydrogen bond donors (number of NH + OH)

4. There are more than 10 hydrogen bond acceptors (number of hydrogen +


oxygen )

5. Molar refractivity should be between 40-130

7
Rate Rate
constant of constant of
absorption
K
dissolution
d K
Solid drug in Drug in solution a Drug systemic
the G.I in the G.I fluid circulation
Fluid
 When Kd << Ka ,dissolution is significantly slower and the absorption is
described as dissolution-rate limited.
 The dissolution rate of drug substance in which surface area is constant
during dissolution is described by Noyes-Whitney equation.
dC/dt=dissolution rate

dC h=diffusion layer thickness


DA
dt  hV (C S  C ) C=solute concentration in bulk solution
V=volume of the dissolution medium
D=diffusion coefficient
A=surface area of the dissolving solid
Cs=solute concentration in the diffusion
layer

8
 Constant surface area is obtained by compressing powder into a disc of
known area with a die and punch apparatus.
 Hydrodynamic conditions are maintained with Static-disc dissolution
apparatus and Rotating disc apparatus
 fig : static dissolution apparatus and rotating disc apparatus

9
STABILITY ANALYSIS
1. Solution stability
2. Solid state stability
SOLUTION STABILITY
 The decomposition of drug occurs through hydrolysis,
oxidation,
photolysis.
 Hydrolysis (anaesthetics, vitamins etc )
a) Ester hydrolysis
R’-COOR + H+ + OH- RCOOH + ROH
ester acid
b) Amide hydrolysis alcohol
RCONHR’ + H+ + OH- RCOOH + H2N-R’
amide acid
amine

10
 Oxidation
 used to evaluate the stability of pharmaceutical preparations
 Eg : steroids, vitamins, antibiotics, epinephrine

 Autoxidation

Materials + molecular oxygen

homolytic fission

Free radicals are produced.


 Oxygen sensitivity is measured
by bubbling air through the
compound or
adding hydrogen peroxide.

11
 Photolysis

pharmaceutical compounds

exposure to uv light

absorbs the radiant


energy

undergoes degradative reactions

SOLID-STATE STABILITY

 1o objective: identification of stable storage conditions.

identification of compatible excipients.


 Solid-state stability depends on the temperature , light, humidity,
12
Solid-State Stability profile of a new
compound

 Samples are placed in open vials and are exposed directly to a variety
of temperatures, humidities, and light intensities for up to 12 weeks.
 Vials exposed to oxygen and nitrogen to study the surface oxidation and
chemical stability , polymorphic changes and discolouration.
 Stability data obtained at various humidities may be linearized with
respect to moisture using the following apparent decay rate constant (KH )

k H
 [gpl].k 0
gpl= concentration of water in atmosphere in units of grams of water per liter
of dry air .
ko = decay rate constant at zero relative humidity
13
 Mole fraction of the solid that has liquefied (Fm ) is
directly proportional to its decay rate.
H 1 1
ln k app  ln F m
 R
fus

[T  T ]
m

 H fus -molar heat of fusion


Tm - absolute
melting point T
-
absolute temperature R
- gas constant
14
Drug- excipient compatibility

 Compatibility test play a very important role in the preformulation


studies of oral dosage forms
 An incompatibility in the dosage form can result in any of the following
changes:
 Changes in organoleptic properties
 Changes in dissolution performance
 Physical form conversion
 An decrease in potency

15
METHOD

Drug + Excipients
(1:1)

Powder samples dispersed into glass ampoules

1 ampoule 1 ampoule (sample


+ water)

stored at a particular temperature (500 C) and analysed


 In emulsions the studies include measuring the critical micelle
concentration of the formulations
 For oral use preparations compatibility of the ingredients
(ethanol, glycerine, syrup, sucrose, buffers and preservatives)
16
17
Stability Studies
During preformulation phase

• Solid-state of the drug alone


• Solution phase
• with the expected excipients
Drug and Drug Product Stability

Evaluation of:
• physical and chemical stability of pure drug substances -
important for preformulation.

Drug Stability : Mechanisms of Degradation


• Chemically drug substances with different
susceptibilities toward chemical instability
Destructive processess
• Hydrolysis
More susceptible to esters, amides, lactones.

• Oxidation
More susceptible to aldehydes, phenols, alcohols.
Drug and Drug Product Stability

Five types:

Chemical Stability
important for selecting:
*storage conditions (temp., light, humidity)
*proper container for dispensing
*anticipating interactions when mixing drugs & dosage
forms
* must know reaction order & rate
• Physical - original physical properties, appearance,
palatability, uniformity, dissolution and suspendability are
retained.

• Microbiologic –sterility/resistance to microbial growth

• Therapeutic –therapeutic effect remains unchanged

• Toxicologic - no significant increase in toxicity occurs.


BCS Classification
• Class I: High solubility, high permeability
(Metoprolol)
• Class II: Low solubility, High permeability
(Aceclofenac)
• Class III: High solubility, Low permeability
(Captopril)
• Class IV: Low solubility, low permeability
(Chlorothiazide)

You might also like